Skip to main content
Profiles and Predictors of Neurodevelopmental Outcome at 5-6 Years in Children With a History of Acute Provoked Neonatal Seizures.
Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis.
High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis.
Recognizing and responding to the needs of future child and adult neurology care through the evolution of residency training.
MOG and AQP4 Antibodies among Children with Multiple Sclerosis and Controls.
Prognostic Discussion for Infants with Neurologic Conditions: Qualitative Analysis of Family Conferences.
Introducing the Child Neurology Society Leadership, Diversity, Equity, and Inclusion Task Force.
Multiple Sclerosis Is Rare in Epstein-Barr Virus-Seronegative Children with Central Nervous System Inflammatory Demyelination.
Randomized Clinical Trial of First-Line Genome Sequencing in Pediatric White Matter Disorders.
Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis.